Nepafenac Catalog No.:M7815-10 A83-01 was orally dosed to

A83-01 was orally dosed to mice at 100-200 mg/kg once per day or intraperitoneally dosed to mice at 10-100 mg/kg once per day

is a n irreversible inhibitor of EGF-receptor (EGFR) kinase activity in vivo (IC50 = 250-490 pM)

Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties

MDV-3100 inhibits the transcriptional activity of a mutant AR protein (W741C

Chemical Name: 3-(2

Nepafenac Catalog No.:M7815-10 A83-01 was orally dosed toNepafenac is a non steroidal anti inflammatory drug (NSAID), usually sold as a prescription eye drop (0. 1% solution. Nepafenac is manufactured by Alcon as Nevanac. It is used to treat pain and inflammation associated with cataract surgery. The usual dose is 1 drop in each affected eye beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. Its side effects may include